Bio Nano Consulting (BNC), a specialist bionanotechnology product development consultancy, has commenced a project with international T cell measurement company Oxford Immunotec
BNC is applying its expertise in nano-characterisation to assist Oxford Immunotec in a project related to its novel Enzyme-Linked Immunospot (Elispot) system.
As specialists in bio-nanotechnology, BNC is able to utilise the world-leading nano-characterisation facilities at the Institute of Biomedical Engineering, Imperial College London.
Oxford Immunotec is commercialising a diagnostic test to detect tuberculosis (TB) based on its patented T-SPOT technology, effectively providing a new way to diagnose and monitor this deadly disease.
The World Health Organization (WHO) has estimated that almost 1.6 million deaths resulted worldwide from TB in 2005.
The developing field of bionanotechnology promises great advances in medicine, particularly in the areas of diagnostics and therapeutics.
By collaborating with Oxford Immunotec, BNC is facilitating the development of precise, accurate techniques to diagnose and monitor infection and disease.
